Motor Neurone Disease Queensland
supporting people living with MND,
their families and carers.  


6/11/2020 - 



The CHAMPION MND/ALS Study is a Phase III, double-blind, randomised, placebo-controlled, parallel-group, multicentre study with an open-label extension period, to evaluate the efficacy and safety of ravulizumab in adult patients with amyotrophic lateral sclerosis (ALS or Motor Neurone Disease/MND). Ravulizumab is an investigational medication not currently approved for use in patients with MND/ALS in any country worldwide.

29/10/2020 - 
MND Queensland recently moved from our old office in Inala, to a larger office and warehouse facility in Oxley.

$25 Million, 25 Milestones: Changing the future of MND

...  read more

Share your story

Do you have a story to share about the impact of the quality, timing and place of care on the lives of people with MND? We invite you to help raise awareness and advocate for the rights of people living with MND by sharing your experiences....  read more

What is MND?

Motor neurone disease (MND) is known as amyotrophic lateral sclerosis (ALS) in many parts of the world. MND is the name given to a group of diseases in which the nerve cells controlling the voluntary muscles undergo degeneration and die....  read more